Dickens DS, Juhl K, Bennett P, Sullivan M, Mancuso A, Parsons SK, Pollock BH. Feasibility of Multi-Institutional Data Collection for Medication Prior Authorization in Pediatric Oncology. JCO Oncol Pract. 2025 Jul;21(7):1017-1023. doi: 10.1200/OP-24-00794. Epub 2025 Jan 31. PMID: 39889257; PMCID: PMC13123271.
Publication Citation
Abstract
Medication prior authorization (mPA) occurs commonly in US cancer care. While medical oncologists report potential harm resulting from this requirement, the impact of mPA in pediatric oncology is unknown. This study’s primary aim was to test the feasibility of prospectively collecting multi-institutional data on mPA in pediatric oncology, while secondarily assessing for resultant delays in care. Pediatric patients with cancer enrolled between September 2021 and December 2022 at three Children’s Oncology Group (COG) institutions participating in the National Cancer Institute Community Oncology Research Program (NCORP). Data collected for each mPA event included the name of the medication, indication, desired initiation date and actual date administered.